U.S. judge in Texas invalidates Allergan patents on Restasis

(Reuters) - Shares of pharmaceutical company Allergan Plc dropped on Monday after a ruling by a U.S. judge invalidated patents on its dry eye medicine Restasis on the grounds that the patents cover obvious ideas.

Source: Reuters: Health - October 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news